These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 22987087)
1. Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology. Knowles SM; Wu AM J Clin Oncol; 2012 Nov; 30(31):3884-92. PubMed ID: 22987087 [TBL] [Abstract][Full Text] [Related]
2. Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications. Fu R; Carroll L; Yahioglu G; Aboagye EO; Miller PW ChemMedChem; 2018 Dec; 13(23):2466-2478. PubMed ID: 30246488 [TBL] [Abstract][Full Text] [Related]
3. Immuno-PET for Clinical Theranostic Approaches. Bailly C; Cléry PF; Faivre-Chauvet A; Bourgeois M; Guérard F; Haddad F; Barbet J; Chérel M; Kraeber-Bodéré F; Carlier T; Bodet-Milin C Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036044 [TBL] [Abstract][Full Text] [Related]
4. Immuno-PET of cancer: a revival of antibody imaging. Boerman OC; Oyen WJ J Nucl Med; 2011 Aug; 52(8):1171-2. PubMed ID: 21764784 [No Abstract] [Full Text] [Related]
5. ImmunoPET to help stratify patients for targeted therapies and to improve drug development. Kraeber-Bodere F; Bailly C; Chérel M; Chatal JF Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2166-2168. PubMed ID: 27539021 [No Abstract] [Full Text] [Related]
6. Engineered antibodies for molecular imaging of cancer. Wu AM Methods; 2014 Jan; 65(1):139-47. PubMed ID: 24091005 [TBL] [Abstract][Full Text] [Related]
7. Copper-64-immunoPET imaging: bench to bedside. Natarajan A Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):356-363. PubMed ID: 33045821 [TBL] [Abstract][Full Text] [Related]
8. Positive progress in immunoPET--not just a coincidence. McCabe KE; Wu AM Cancer Biother Radiopharm; 2010 Jun; 25(3):253-61. PubMed ID: 20578830 [TBL] [Abstract][Full Text] [Related]
9. Current Perspectives on Yoon JK; Park BN; Ryu EK; An YS; Lee SJ Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560337 [No Abstract] [Full Text] [Related]
10. Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments. Li K; Tavaré R; Zettlitz KA; Mumenthaler SM; Mallick P; Zhou Y; Marks JD; Wu AM Mol Cancer Ther; 2014 Nov; 13(11):2607-17. PubMed ID: 25143449 [TBL] [Abstract][Full Text] [Related]
11. ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience. de Lucas ÁG; Lamminmäki U; López-Picón FR Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671549 [TBL] [Abstract][Full Text] [Related]
12. ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts. Cheal SM; Ruan S; Veach DR; Longo VA; Punzalan BJ; Wu J; Fung EK; Kelly MP; Kirshner JR; Giurleo JT; Ehrlich G; Han AQ; Thurston G; Olson WC; Zanzonico PB; Larson SM; Carrasquillo JA Mol Pharm; 2018 Jun; 15(6):2133-2141. PubMed ID: 29684277 [TBL] [Abstract][Full Text] [Related]
13. Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies. England CG; Rui L; Cai W Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):517-532. PubMed ID: 27844106 [TBL] [Abstract][Full Text] [Related]
14. Emerging role of immunoPET in receptor targeted cancer therapy. Marik J; Junutula JR Curr Drug Deliv; 2011 Jan; 8(1):70-8. PubMed ID: 21034420 [TBL] [Abstract][Full Text] [Related]